• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Time to Stop Using Ineffective Covid-19 Drugs.

作者信息

Abdool Karim Salim S, Devnarain Nikita

机构信息

From the Centre for the AIDS Programme of Research in South Africa, Durban (S.S.A.K., N.D.); and the Department of Epidemiology, Mailman School of Public Health, Columbia University, New York (S.S.A.K.).

出版信息

N Engl J Med. 2022 Aug 18;387(7):654-655. doi: 10.1056/NEJMe2209017.

DOI:10.1056/NEJMe2209017
PMID:36070715
Abstract
摘要

相似文献

1
Time to Stop Using Ineffective Covid-19 Drugs.是时候停止使用无效的新冠病毒药物了。
N Engl J Med. 2022 Aug 18;387(7):654-655. doi: 10.1056/NEJMe2209017.
2
Repurposed Drugs Failed to Prevent Severe COVID-19.重新利用的药物未能预防重症 COVID-19。
JAMA. 2022 Sep 27;328(12):1171. doi: 10.1001/jama.2022.14723.
3
Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.用于严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的药物重新利用：2019冠状病毒病（COVID-19）药物可及性的新见解
Expert Rev Anti Infect Ther. 2022 Sep;20(9):1187-1204. doi: 10.1080/14787210.2022.2082944. Epub 2022 Jun 6.
4
Corticosteroids prescription for mild-moderate COVID-19 in Primary Care.基层医疗中针对轻至中度新型冠状病毒肺炎的皮质类固醇处方
J Infect Dev Ctries. 2021 Dec 31;15(12):1813-1815. doi: 10.3855/jidc.15069.
5
What makes (hydroxy)chloroquine ineffective against COVID-19: insights from cell biology.（羟）氯喹对抗 COVID-19 无效的原因：细胞生物学的见解。
J Mol Cell Biol. 2021 Jul 6;13(3):175-184. doi: 10.1093/jmcb/mjab016.
6
Identification of Drug Interaction Adverse Events in Patients With COVID-19: A Systematic Review.识别 COVID-19 患者中的药物相互作用不良事件：一项系统评价。
JAMA Netw Open. 2022 Apr 1;5(4):e227970. doi: 10.1001/jamanetworkopen.2022.7970.
7
Both Chloroquine and Lopinavir/Ritonavir Are Ineffective for COVID-19 Treatment and Combined Worsen the Pathology: A Single-Center Experience with Severely Ill Patients.氯喹和洛匹那韦/利托那韦对 COVID-19 治疗无效，联合使用会加重病情：重症患者的单中心经验。
Biomed Res Int. 2021 Feb 6;2021:8821318. doi: 10.1155/2021/8821318. eCollection 2021.
8
The shortcomings of tocilizumab in COVID-19.托珠单抗在治疗新型冠状病毒肺炎中的不足之处。
Infez Med. 2020 Dec 1;28(4):465-468.
9
'A very, very bad look' for remdesivir.瑞德西韦的情况“非常、非常不妙”。
Science. 2020 Nov 6;370(6517):642-643. doi: 10.1126/science.370.6517.642.
10
Pre-Exposure Prophylaxis with Hydroxychloroquine Does Not Prevent COVID-19 nor Virus Related Venous Thromboembolism.羟氯喹的暴露前预防并不能预防 COVID-19 或与之相关的静脉血栓栓塞症。
Viruses. 2021 Oct 13;13(10):2052. doi: 10.3390/v13102052.

引用本文的文献

1
Mismanagement of SARS-CoV-2 Infection Pre Hospitalisation during the Omicron Era: Antibiotics and Steroids Instead of Early Antivirals.奥密克戎时代下，对 SARS-CoV-2 感染住院前管理的失误：抗生素和类固醇，而非早期抗病毒药物。
Viruses. 2024 Jun 22;16(7):1005. doi: 10.3390/v16071005.
2
Why Certain Repurposed Drugs Are Unlikely to Be Effective Antivirals to Treat SARS-CoV-2 Infections.为何某些重新利用的药物不太可能成为治疗新冠病毒感染的有效抗病毒药物。
Viruses. 2024 Apr 22;16(4):651. doi: 10.3390/v16040651.
3
Case Report on High Dose Lithium Treatment for Post-COVID Depression, Recurrent Fevers, and Skin Lesions.
新冠后抑郁、反复发热和皮肤损伤的高剂量锂治疗病例报告。
Psychopharmacol Bull. 2024 Apr 4;54(2):39-45.
4
Immunogenicity and adverse events of the COVID-19 vaccines in healthy and individuals with autoimmune diseases in an Iranian population.伊朗人群中 COVID-19 疫苗的免疫原性和不良反应在健康人群和自身免疫性疾病患者中的表现。
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241239202. doi: 10.1177/03946320241239202.
5
Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19.SARS-CoV-2 刺突蛋白与血液和血管内皮细胞的唾液酸化聚糖结合决定了 COVID-19 的严重发病机制。
Int J Mol Sci. 2023 Dec 1;24(23):17039. doi: 10.3390/ijms242317039.
6
Off-label drug use during the COVID-19 pandemic in Africa: topic modelling and sentiment analysis of ivermectin in South Africa and Nigeria as a case study.非洲 COVID-19 大流行期间的标签外用药：以南非和尼日利亚的伊维菌素为例的主题建模和情绪分析。
J R Soc Interface. 2023 Sep;20(206):20230200. doi: 10.1098/rsif.2023.0200. Epub 2023 Sep 13.
7
COVID-19 Excess Deaths in Peru's 25 States in 2020: Nationwide Trends, Confounding Factors, and Correlations With the Extent of Ivermectin Treatment by State.2020年秘鲁25个州的新冠疫情超额死亡情况：全国趋势、混杂因素以及与各州伊维菌素治疗范围的相关性
Cureus. 2023 Aug 8;15(8):e43168. doi: 10.7759/cureus.43168. eCollection 2023 Aug.
8
Modeling the dynamics of COVID-19 with real data from Thailand.利用泰国的真实数据对 COVID-19 疫情进行建模。
Sci Rep. 2023 Aug 11;13(1):13082. doi: 10.1038/s41598-023-39798-9.
9
Mendelian randomization analysis identified tumor necrosis factor as being associated with severe COVID-19.孟德尔随机化分析确定肿瘤坏死因子与重症新型冠状病毒肺炎相关。
Front Pharmacol. 2023 Jun 16;14:1171404. doi: 10.3389/fphar.2023.1171404. eCollection 2023.
10
When Characteristics of Clinical Trials Require Per-Protocol as Well as Intention-to-Treat Outcomes to Draw Reliable Conclusions: Three Examples.当临床试验的特征需要按方案分析以及意向性分析结果才能得出可靠结论时：三个实例
J Clin Med. 2023 May 23;12(11):3625. doi: 10.3390/jcm12113625.